Quinfosys™ QuDrugForge

Unlock the power of in silico biochemistry. QuDrugForge integrates quantum molecular screening with generative intelligence to identify high-affinity lead candidates.

• Target discovery workflows

  Identify, prioritize, and validate disease-driving genomic targets with advanced bioinformatic maps.

• Molecule generation and screening

  Generative reinforcement learning pipelines designed to filter and design millions of novel candidate structures.

• Docking, GNINA, and quantum reranking

  Accelerate binding affinity calculations utilizing deep convolutional neural networks and molecular mechanics scoring.

• Candidate dossiers and validation reports

  Automated preparation of FDA 21 CFR Part 11 compliant evidence packages and real-time ADMET profiling data.